Jennifer Schumi

Most-cited papers

1. Prediction intervals for neural networks via nonlinear regression

   Richard D. de Veaux, Jennifer Schumi, Jason Schweinsberg, L. Ungar

   1998196 citations

   Semantic Scholar

   Save

2. Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial.

   J. Tardif, J. McMurray, E. Klug, R. Small +7 more

   2008The Lancet190 citations

   Semantic Scholar

   Save

3. Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease

   A. M. Wessels, P. Tariot, Jennifer A. Zimmer, Katherine J. Selzler +18 more

   2019JAMA Neurology160 citations Open access

   Semantic Scholar

   Save

4. Market watch: Changes in physician supply and scope of practice during a malpractice crisis: Evidence from Pennsylvania

   Michelle M. Mello, D. Studdert, Jennifer Schumi, T. Brennan +1 more

   200733 citations Open access

   Semantic Scholar

   Save

5. ETESIAN: A PHASE 2B STUDY OF THE EFFICACY, SAFETY AND TOLERABILITY OF AZD8233, A PCSK9-TARGETED ANTISENSE OLIGONUCLEOTIDE, IN PATIENTS WITH DYSLIPIDEMIA

   M. Koren, A. Hofherr, Jennifer Schumi, D. Rekić +6 more

   2022Journal of the American College of Cardiology24 citations Open access

   Semantic Scholar

   Save

6. Hepatic patatin‐like phospholipase domain‐containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans

   Elke Ericson, L. Bergenholm, A. Andréasson, Carly I Dix +12 more

   2022Hepatology Communications22 citations Open access

   Semantic Scholar

   Save

7. Disease Modification in Alzheimer’s Disease: Current Thinking

   H. Liu-Seifert, Jennifer Schumi, Xiao-Peng Miao, Ying Tian +5 more

   2020Therapeutic Innovation and Regulatory Science11 citations

   Semantic Scholar

   Save

8. Disease Modification in Alzheimer's Disease: Current Thinking.

   H. Liu-Seifert, Jennifer Schumi, Xiao-Peng Miao, Ying Tian +5 more

   2019Therapeutic Innovation and Regulatory Science9 citations

   Semantic Scholar

   Save

9. Resampling‐based analyses of the effects of combinations of HIV genetic mutations on drug susceptibility

   Jennifer Schumi, V. DeGruttola

   2008Statistics in Medicine6 citations

   Semantic Scholar

   Save

10. Abstract 11482: The PCSK9-Targeted Antisense Oligonucleotide AZD8233 Reduces LDL-C, ApoB, and Lp(a) in Patients With Dyslipidemia on Statin Treatment - Data From the Phase 2b ETESIAN Study

    A. Hofherr, Jennifer Schumi, Anna Rudvik, R. Vega +4 more

    2022Circulation5 citations

    Semantic Scholar

    Save

11. Assessment of the Cardiovascular Risk of Olmesartan Medoxomil-Based Treatment: Meta-Analysis of Individual Patient Data

    Antonia C. Wang, U. Stellmacher, Jennifer Schumi, N. Tu +1 more

    2016American Journal of Cardiovascular Drugs2 citations

    Semantic Scholar

    Save

12. DT‐01‐04: LANABECESTAT: BASELINE CHARACTERISTICS OF PARTICIPANTS RANDOMIZED IN THE PHASE 2/3 AMARANTH STUDY

    J. Sims, A. M. Downing, Scott W. Andersen, A. M. Wessels +9 more

    20181 citations

    Semantic Scholar

    Save

13. The International Journal of Biostatistics Testing for Associations with Missing High-Dimensional Categorical Covariates

    Jennifer Schumi, A. DiRienzo, V. DeGruttola

    20111 citations

    Semantic Scholar

    Save

14. Changes In Physician Supply And Scope Of Practice During A Malpractice Crisis: Evidence

    Michelle M. Mello, D. Studdert, Jennifer Schumi, William M. Sage

    20071 citations

    Semantic Scholar

    Save